GSK to buy RAPT Therapeutics in $2.2 billion deal by LLB Finance Reporter January 20, 2026 January 20, 2026
Novo Nordisk Q1 results: ‘Strong performance’ and ‘rosy outlook’ expected by Thea Coates Finance Reporter May 2, 2024 May 2, 2024
Novo Nordisk’s record-breaking growth highlights ‘insatiable demand’ for weight loss drugs by LLB Finance Reporter February 1, 2024 February 1, 2024
Pfizer slumped by 36%, is it a good buy in 2024? by Thea Coates Finance Reporter January 25, 2024 January 25, 2024
EBRD invests €25 million in pharmaceutical company Pelion by LLB Finance Reporter December 21, 2023 December 21, 2023
UK challenger consultancy makes acquisition amidst wider Big Four restructuring by LLB Reporter December 11, 2023 December 11, 2023
A decade of penalties: Big pharma paid over $80 billion in fines since 2010 by LLB Finance Reporter October 19, 2023 October 19, 2023
Pharmaceutical sector continues to fall short on job applicants by LLB Reporter August 2, 2022 August 2, 2022
Pfizer’s new Covid wonderpill cuts hospitalisations and death by 89% by LLB Reporter November 5, 2021 November 5, 2021
Which UK stocks have done best since Pfizer Monday? by LLB Reporter November 4, 2021 November 4, 2021
